Assessment of the in vitro cytochrome P450 (CYP) inhibition potential of nafithromycin, a next generation lactone ketolide antibiotic-Reference-Cited by-同舟云学术

Assessment of the in vitro cytochrome P450 (CYP) inhibition potential of nafithromycin, a next generation lactone ketolide antibiotic

Published:2020-11-16 Issue:3 Volume:51 Page:251-261
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Chavan Rajesh¹^ORCID,Zope Vineet¹,Chavan Nilesh¹,Patil Kiran¹^ORCID,Yeole Ravindra¹^ORCID,Bhagwat Sachin¹^ORCID,Patel Mahesh¹^ORCID

Affiliation:

1. Wockhardt Research Centre, Aurangabad, India

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/00498254.2020.1839983

Reference24 articles.

1. Advanced Life Sciences, 2009. FDA briefing document: cethromycin tablets. Available from: www.accessdata.fda.gov

2. Bayer HealthCare Pharmaceuticals Inc. 2010. Highlights of prescribing Information: AVELOX (moxifloxacin hydrochloride) Film coated tablet, injection, solution for IV use. Available from: www.accessdata.fda.gov/drugsatfda_docs/label

3. Bayer HealthCare Pharmaceuticals Inc., 2016. Highlights of prescribing Information: CIPRO (ciprofloxacin hydrochloride) tablet for oral use, oral suspension. Available from: www.accessdata.fda.gov/drugsatfda_docs/label

4. BGP Pharma ULC, 2016. Product monograph: BIAXIN (clarithromycin for oral suspension USP 125 mg/5 mL and 250 mg/5 mL). Available from: www.accessdata.fda.gov/drugsatfda_docs/label

5. Cempra Pharmaceuticals Inc. 2016. FDA briefing document: solithromycin for CABP. Available from: www.accessdata.fda.gov

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nafithromycin (MIQNAF®): ultramodern lactone ketolide designed to treat community acquired bacterial pneumonia (CABP);Medicinal Chemistry Research;2024-07-23

2. Antibiotic resistance: a global crisis, problems and solutions;Critical Reviews in Microbiology;2024-02-21

3. Antistaphylococcal discovery pipeline; where are we now?;European Journal of Medicinal Chemistry;2024-02

4. A New Process for the Synthesis of R‐nosylate a Key Intermediate of Nafithromycin;ChemistrySelect;2024-01-02

5. Design and development of efficient synthetic strategies for the chiral synthesis of novel ketolide antibiotic, nafithromycin (WCK 4873);Chemical Papers;2023-02-24